Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 5
2008 3
2009 2
2010 4
2011 11
2012 14
2013 14
2014 10
2015 6
2016 8
2017 12
2018 11
2019 13
2020 4
2021 6
2022 8
2023 12
2024 5
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Results by year

Filters applied: . Clear all
Page 1
Long-term safety of canakinumab in patients with systemic juvenile idiopathic arthritis: 5-year results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry.
Correll C, Burciu A, Bansal A, Dennos A, Narayanswamy D, Aubrun E, Schanberg LE, Yuhan L, Schneider R, Balevic S, Kimura Y, Beukelman T; CARRA Registry investigators. Correll C, et al. Among authors: beukelman t. Pediatr Rheumatol Online J. 2025 Oct 21;23(1):105. doi: 10.1186/s12969-025-01144-w. Pediatr Rheumatol Online J. 2025. PMID: 41121260 Free PMC article.
Comparative Effectiveness of a Second Tumor Necrosis Factor Inhibitor Versus a Non-Tumor Necrosis Factor Biologic in the Treatment of Patients With Polyarticular-Course Juvenile Idiopathic Arthritis.
Mannion ML, Amin S, Balevic S, Chang ML, Correll CK, Kearsley-Fleet L, Hyrich KL, Beukelman T; Childhood Arthritis and Rheumatology Research Alliance Registry Investigators and the UK Juvenile Idiopathic Arthritis Biologics Register Investigators. Mannion ML, et al. Among authors: beukelman t. Arthritis Care Res (Hoboken). 2024 Aug;76(8):1090-1098. doi: 10.1002/acr.25339. Epub 2024 May 7. Arthritis Care Res (Hoboken). 2024. PMID: 38556945 Free PMC article.
Using Research Networks to Compare Medicines for Autoimmune and Inflammatory Diseases – The Comparative Health Outcomes in Immune-mediated diseases CollaborativE (CHOICE) Study [Internet].
Curtis J, Beukelman T, Annapureddy N, Oates J, Clowse M, Long M, Kappelman M, Bailey C, Ringold S, Rhee R, Merkel P, Nowell B, Chen L, Xie F, Clinton C. Curtis J, et al. Among authors: beukelman t. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2023 Oct. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2023 Oct. PMID: 41026865 Free Books & Documents. Review.
139 results